South Staffordshire Joint FormularyCannock Chase Clinical Commissioning Group East Staffordshire Clinical Commissioning Group South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group Stafford and Surrounds Clinical Commissioning Group
Spironolactone has been shown to reduce symptoms and mortality in patients with Grade III or Grade IV heart failure. Careful monitoring of U&E's is required.
Eplerenone 25mg Tablet Eplerenone 50mg Tablet
For patients with left ventricular dysfunction following myocardial infarction (start therapy within 3-14 days of the event, as per BNF). Careful monitoring of U&E's is required Consider changing to spironolactione once stable.
Once patient in stabilised prescribing can continue in primary care. A RICad or prescribing supporting information will be provided